Trading a AUPH straddle lets you take a pure volatility position on Aurinia Pharmaceuticals Inc without committing to a direction. Aurinia Pharmaceuticals Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate AUPH straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on AUPH profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Aurinia Pharmaceuticals Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the AUPH straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the AUPH straddle is the cleanest expression of that view. Our scanner prices every AUPH straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a AUPH straddle into a catalyst or short a AUPH straddle to harvest decay, the options straddle setups that matter are all in one place.
